Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 08 December 2025

Sec. Neuropharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1751557

Correction: Neuroprotective role of carvacrol in ischemic brain injury: a systematic review of preclinical evidence and proposed TRPM7 involvement

This article is a correction to:

  1. Neuroprotective role of carvacrol in ischemic brain injury: a systematic review of preclinical evidence and proposed TRPM7 involvement

    1. Read original article
Abdulrahman M. KhojahAbdulrahman M. Khojah1Hussain Al Dera, Hussain Al Dera1,2*
  • 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
  • 2King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia

A Correction on
Neuroprotective role of carvacrol in ischemic brain injury: a systematic review of preclinical evidence and proposed TRPM7 involvement

by Khojah AM and Al Dera H (2025). Front. Pharmacol. 16:1687119. doi: 10.3389/fphar.2025.1687119

There was a mistake in Table 1 as published. The references added to the first column were inserted incorrectly. The corrected Table 1 appears below.

Table 1
www.frontiersin.org

Table 1. Baseline characteristics of included studies.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: carvacrol, TRPM7, ischemic stroke, global cerebral ischemia, neuroprotection, oxidative stress, apoptosis

Citation: Khojah AM and Al Dera H (2025) Correction: Neuroprotective role of carvacrol in ischemic brain injury: a systematic review of preclinical evidence and proposed TRPM7 involvement. Front. Pharmacol. 16:1751557. doi: 10.3389/fphar.2025.1751557

Received: 21 November 2025; Accepted: 24 November 2025;
Published: 08 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Khojah and Al Dera. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hussain Al Dera, ZGVyYTE0NDRAaG90bWFpbC5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.